Cellular DNA and cellular proteins in proliferating tumor cells

Cellular DNA and cellular proteins in proliferating tumor cells refers to a broad set of biological components that serve as the primary sites of action for traditional cytotoxic chemotherapy. This category encompasses the cell's genetic blueprint (DNA) and essential machinery, such as topoisomerases and microtubules, which are critical for the rapid growth and division of malignant cells (Source: NIH, National Cancer Institute). Drugs targeting these elements, including alkylating agents and antimetabolites, work by inducing DNA damage or inhibiting the synthesis of nucleic acids and proteins, thereby triggering cell cycle arrest or apoptosis (Source: StatPearls, "Cancer Chemotherapy"). Because these targets are fundamental to the cell cycle, they are highly active in proliferating tumor cells, making them effective for reducing tumor burden. However, these components are also present in healthy, rapidly dividing tissues such as the bone marrow, hair follicles, and gastrointestinal lining (Source: American Cancer Society). This lack of specificity leads to the characteristic side effects of chemotherapy, such as myelosuppression and mucositis. Consequently, while these are valid therapeutic sites, they represent a non-specific approach compared to modern targeted therapies that focus on unique oncogenic drivers.

Other names

Cytotoxic targetsProliferation-associated targetsMacromolecular targets of chemotherapy

Drugs targeting these components act through various mechanisms including DNA alkylation, intercalation, inhibition of DNA polymerase, and disruption of microtubule assembly or disassembly (Source: StatPearls, "Antineoplastic Agents").